Cargando…

Triple negative breast cancer: A continuing challenge

Detalles Bibliográficos
Autor principal:	Gupta, Sudeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715970/ https://www.ncbi.nlm.nih.gov/pubmed/23878477 http://dx.doi.org/10.4103/0971-5851.113393

Ejemplares similares

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Stratifying the stratifiers of triple negative breast cancer
por: Wang, Dong-Yu, et al.
Publicado: (2020)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case–control study
por: Nag, Shona, et al.
Publicado: (2023)

Sacituzumab govitecan in triple-negative breast cancer
por: de Nonneville, Alexandre, et al.
Publicado: (2022)

Stratifying triple-negative breast cancer: which definition(s) to use?
por: Adamo, Barbara, et al.
Publicado: (2011)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon, Joëlle, et al.
Publicado: (2016)

Triple Negative Breast Cancer: Nanosolutions for a Big Challenge
por: Mendes, Tânia Filipa S., et al.
Publicado: (2015)

Achilles' heel of triple negative cancer
por: Ocaña, Alberto, et al.
Publicado: (2014)

Achilles' heel of triple negative cancer
por: Ocaña, Alberto, et al.
Publicado: (2014)

Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
por: Mediratta, Karan, et al.
Publicado: (2020)

Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2018)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Endobronchial metastasis: The challenge continues
por: Gupta, Neeraj
Publicado: (2019)

Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer
por: Rozenblit, Mariya, et al.
Publicado: (2022)

Targeting BCL6 and STAT3 in triple negative breast cancer: the one-two punch?
por: Walker, Sarah R., et al.
Publicado: (2015)

Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
por: Gandhi, Shipra
Publicado: (2023)

Breast cancer: Indian experience, data, and evidence
por: Gupta, Sudeep
Publicado: (2016)

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
por: Lee, Jin Sun, et al.
Publicado: (2020)

Research advances and new challenges in overcoming triple-negative breast cancer
por: Zong, Yu, et al.
Publicado: (2021)

Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
por: Chapdelaine, Abygail G., et al.
Publicado: (2023)

Mammographic screening for breast cancer: Are the chickens coming home to roost?
por: Badwe, Rajendra A., et al.
Publicado: (2013)

Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
por: Mahmoud, Rinad, et al.
Publicado: (2022)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy
por: Walsh, Elaine M., et al.
Publicado: (2018)

Treatment response in triple-negative breast cancer: a role for eEF2 kinase-mediated autophagy?
por: Ho, Cally J., et al.
Publicado: (2020)

Editorial: Targeting triple negative breast cancer by natural compounds
por: Kumar, Shashank, et al.
Publicado: (2023)

Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
por: Maltoni, Roberta, et al.
Publicado: (2022)

Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?
por: Franzoi, Maria Alice, et al.
Publicado: (2020)

Overview of triple negative breast cancer prognostic signatures in the context of data science-driven clinico-genomics research
por: Capobianco, Enrico
Publicado: (2022)

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
por: Yang, Ruoning, et al.
Publicado: (2022)

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
por: Alaouna, Mohammed, et al.
Publicado: (2023)

The challenge continues
Publicado: (2018)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ei7t546ubnfgq7f6urj2ie8g6